High levels of hyaluronan in idiopathic pulmonary arterial hypertension.
Hyaluronan (HA), a large glycosaminoglycan found in the ECM, has major roles in lung and vascular biology and disease. However, its role in idiopathic pulmonary arterial hypertension (IPAH) is unknown. We hypothesized that HA metabolism is abnormal in IPAH. We measured the plasma levels of HA in IPAH and healthy individuals. We also evaluated HA synthesis and the expression of HA synthases and hyaluronidases in pulmonary artery smooth muscle cells (PASMCs) from explanted lungs. Plasma HA levels were markedly elevated in IPAH compared with controls [HA (ng/ml, mean +/- SD): IPAH 325 +/- 80, control 28 +/- 9; P = 0.02]. In vitro, unstimulated IPAH PASMCs produced high levels of HA compared with control cells [HA in supernatant (microg/ml, mean +/- SD): IPAH 12 +/- 2, controls 6 +/- 0.9; P = 0.04]. HA levels were also higher in IPAH PASMC lysates. The increased HA was biologically relevant as shown by tissue staining and increased HA-specific binding of mononuclear cells to IPAH compared with control PASMCs [number of bound cells x 10(4) (mean +/- SD): IPAH 9.5 +/- 3, control 3.0 +/- 1; P = 0.01]. This binding was abrogated by the addition of hyaluronidase. HA synthase-2 and hyaluronidase-2 were predominant in control and IPAH PASMCs. Interestingly, the expressions of HA synthase-2 and hyaluronidase-2 were approximately 2-fold lower in IPAH compared with controls [HA synthase-2 (relative expression mean +/- SE): IPAH 4.3 +/- 0.02, control 7.8 +/- 0.1; P = 0.0004; hyaluronidase-2 (relative expression mean +/- SE): IPAH 4.2 +/- 0.06, control 7.6 +/- 0.07; P = 0.008]. Thus patients with IPAH have higher circulating levels of HA, and PASMCs derived from IPAH lungs produce more HA compared with controls. This is associated with increased tissue levels and increased binding of inflammatory cells suggesting a role for HA in remodeling and inflammation in IPAH.
Aytekin
Metin
M
Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195, USA.
Comhair
Suzy A A
SA
de la Motte
Carol
C
Bandyopadhyay
Sudip K
SK
Farver
Carol F
CF
Hascall
Vincent C
VC
Erzurum
Serpil C
SC
Dweik
Raed A
RA
D000328:Adult; D016022:Case-Control Studies; D002448:Cell Adhesion; D004721:Endoplasmic Reticulum / Q000473:pathology; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D014453:Glucuronosyltransferase / Q000235:genetics / Q000378:metabolism; D006801:Humans; D006820:Hyaluronic Acid / Q000097:blood* / Q000737:chemistry; D006821:Hyaluronoglucosaminidase / Q000235:genetics / Q000378:metabolism; D006976:Hypertension, Pulmonary / Q000097:blood* / Q000201:enzymology; D007249:Inflammation / Q000473:pathology; D007527:Isoenzymes / Q000378:metabolism; D008168:Lung / Q000378:metabolism / Q000473:pathology; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D008970:Molecular Weight; D032389:Myocytes, Smooth Muscle / Q000201:enzymology / Q000378:metabolism; D011651:Pulmonary Artery / Q000201:enzymology / Q000378:metabolism*; D020298:U937 Cells
D007527:Isoenzymes; D006820:Hyaluronic Acid; D014453:Glucuronosyltransferase; D006821:Hyaluronoglucosaminidase
N Engl J Med. 2004 Oct 14;351(16):1655-65
15483284
Cleve Clin J Med. 2003 Apr;70 Suppl 1:S2-8
12716137
J Biol Chem. 2003 Nov 21;278(47):47223-31
12954638
Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):1004-13
10195929
Am J Respir Crit Care Med. 1998 Sep;158(3):917-23
9731026
Am J Hematol. 1995 Dec;50(4):231-3
7485095
Inflamm Res. 2006 Feb;55(2):72-7
16612567
Thorax. 1989 Feb;44(2):126-31
2928996
Connect Tissue Res. 1990;24(3-4):219-24
2376124
J Biol Chem. 1984 Apr 25;259(8):5017-23
6425282
Am J Pathol. 2003 Jul;163(1):121-33
12819017
Nat Med. 1999 Jul;5(7):745-51
10395318
FASEB J. 1992 Apr;6(7):2397-404
1563592
J Cell Physiol. 2006 Feb;206(2):378-85
16110480
Clin Chim Acta. 2004 Oct;348(1-2):189-97
15369754
FASEB J. 2004 Nov;18(14):1746-8
15364894
Am J Physiol Lung Cell Mol Physiol. 2008 Jan;294(1):L24-33
17965319
J Biol Chem. 1999 Oct 22;274(43):30747-55
10521464
J Clin Invest. 2002 Nov;110(10):1389-98
12438434
J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):13S-24S
15194174
N Engl J Med. 1995 Jul 27;333(4):214-21
7540722
Am J Physiol Lung Cell Mol Physiol. 2000 Nov;279(5):L825-34
11053016
Biochim Biophys Acta. 2004 Jul 6;1673(1-2):3-12
15238245
Science. 2002 Apr 5;296(5565):155-8
11935029
Am J Pathol. 1994 Feb;144(2):275-85
7508683
J Biol Chem. 1999 Aug 27;274(35):25085-92
10455188
Int J Biochem. 1992 Mar;24(3):465-70
1551458
Eur J Cell Biol. 2006 Aug;85(8):699-715
16822580
Histopathology. 1990 Jan;16(1):9-19
2307421
Science. 1985 Jun 14;228(4705):1324-6
2408340
Circ Res. 2007 Mar 30;100(6):923-9
17332430
J Biol Chem. 2004 Mar 12;279(11):10279-85
14679194
Biochem J. 1995 May 1;307 ( Pt 3):817-21
7741713
Ann Intern Med. 1987 Aug;107(2):216-23
3605900
Adv Exp Med Biol. 2005;566:249-56
16594159
Eur Respir J. 2003 Aug;22(2):358-63
12952274
Scand J Clin Lab Invest. 1992 Nov;52(7):613-21
1455153
Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3261-7
11006212
Int J Cancer. 2002 Feb 1;97(4):416-24
11802201
Am J Respir Crit Care Med. 2003 May 1;167(9):1169-75
12714341
Methods. 2001 Dec;25(4):402-8
11846609
Biochem J. 1986 Oct 15;239(2):445-50
3101667
Anal Biochem. 2002 Sep 15;308(2):255-64
12419337
Brain. 2006 Aug;129(Pt 8):2158-76
16731541
Biochem J. 1978 Aug 1;173(2):565-8
697736
J Clin Invest. 2002 Nov;110(10):1383-8
12438433
Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9881-5
7568237
J Intern Med. 1997 Jul;242(1):67-71
9260569
EMBO J. 2001 Jun 15;20(12):3082-91
11406585
Semin Cancer Biol. 2008 Aug;18(4):251-9
18450475
Am J Physiol Lung Cell Mol Physiol. 2008 Feb;294(2):L205-13
18032699
Am J Respir Crit Care Med. 2005 Aug 1;172(3):352-7
15879413